Peptide marketing · RUO · Compliance-first

Compliance-first growth for RUO peptide brands. We scale research peptide brands inside the lines.

For peptide brand founders doing $20K to $2M+ per month who are stuck on Meta and Google bans, missing an affiliate program, or being out-scaled. RUO is a compliance posture, not a marketing license. We treat it that way.

Book a Strategy Call See the Playbook
RUOCompliance posture, not license
50-100Affiliates in 90 days
30-50%Email/SMS revenue target
1/qtrPer niche · vertical exclusive
Operator track record · verifiable

The numbers behind the playbook.

Strategic partners include Kirk Perron (founder of Jamba Juice), top-performing McDonald’s franchisees, functional medicine MDs, ketamine clinic operators, and Monster Energy / Red Bull-sponsored athletes. See the full founder story →

12 yrs
Inside health, wellness & behavioral health
Marketer + operator. Full founder story →
2 sold
Sub-acute detox locations sold 2025
Fresh Start of California Detox. Founder timeline →
$12M
Raised at SoCal Mental Health
Multi-program platform. Founder timeline →
$580K+
Raised for behavioral health & wellness fundraisers
Mental health, addiction, recovery causes. Founder timeline →
20K+
Copies of The Epic Journal sold
1,000-1,500 monthly organic. Behavioral health →
21+
5-star Google reviews on sister co.
Epic Journey Recovery. epicjourneyrecovery.co
Why we do this work

This is not a vertical we picked. It is the one we lost people in.

In 2015 Preston’s father died by suicide. The same year, he and his brother opened the first detox. Years later, his brother passed away from a fentanyl overdose. Friends in the same orbit have been lost to illness and addiction since.

That is the reason PELORA exists, and the reason it stays in this category. It is also the reason a peptide brand, a longevity clinic, a treatment center, or a functional medicine practice gets a different level of work from us than they would from a generalist agency.

“The companies we work for are the ones helping people get better. The work is personal because of who I lost. We do not pretend it isn’t.”

The promise. If your business helps people live happier, healthier, longer, more active lives, our job is to make sure people find you, choose you, and have a great experience working with you. We will make you money. We will treat your customers like ours. Read the full founder timeline →

The reality

Why generalist agencies fail in peptides.

Three things every peptide founder needs to internalize before they hire any agency.

Reality 01

Meta and Google banned direct peptide ads.

Both platforms classify peptides as unapproved pharmaceuticals. Direct PDP ads are functionally dead since the 2023 enforcement waves. Account hygiene buys runway, not approval.

Reality 02

FDA escalated against brand-side copy.

The 2024-2025 FDA warning letter wave focused on brands whose own copy crossed structure-function or disease-treatment lines, not properly contracted affiliates. Brand copy is the single biggest insulator.

Reality 03

The brands winning built it on coded affiliates.

Every peptide brand past $10M ARR built it on coded affiliate networks, micro and nano influencers, owned email and SMS, long-tail SEO, and podcast or YouTube host-reads. RUO is the legal shield.

If your last agency tried to run direct Meta peptide ads, you already know what happens. We do not. Book a 30-min strategy call to see what works.

Book a Strategy Call
The Pelora operating system

Six pillars. Compliance is the operating system, not an afterthought.

This is where peptide founders decide we know what we are doing. Each pillar is a deliverable, not a slide.

Pillar 01 · Foundation

Compliance Foundation

Brand copy lives or dies on this. We audit against current FDA and FTC enforcement patterns, install the legal scaffolding, and protect every channel downstream.

  • Brand copy audit: structure/function language, RUO disclaimer placement, age-gate, ID verification.
  • Affiliate MSA template: claim restrictions, indemnification, content approval workflow.
  • COA / purity / mass spec presentation standard so lab data converts.
  • Email / SMS legal layer: disclaimers, opt-in flow, suppression list hygiene.
Pillar 02 · Engine

Affiliate Program Build & Operations

The affiliate program is the engine. Not paid media. We build the platform, write the contracts, recruit the codes, and audit performance every month.

  • Platform setup: Refersion, GoAffPro, or custom build.
  • Tier structure: 15-25% commission, 10-20% off codes, performance tiers.
  • Recruiting pipeline: 50-100 micro/nano in 90 days across bodybuilding, biohacking, longevity, men's health, peri/post-menopausal women's health.
  • Private Telegram or Discord with monthly drops and leaderboard.
  • Monthly performance audit. Non-performing codes retired.
Pillar 03 · Distribution

Influencer Tier Strategy

Nano (1K-10K) and micro (10K-100K) are the engine. Highest engagement, lowest cost, manageable compliance. Macro is selective. Mega is generally avoided in pure RUO.

  • Nano + micro = 70% of influencer effort. Pre-qualified, niche-deep audiences.
  • Macro (100K-1M) reserved for cosmetic peptides or nootropic-adjacent SKUs with ad cover.
  • Mega/celebrity avoided in pure RUO. Reserved for licensed compounding-pharmacy plays.
  • Vetting: Modash, HypeAuditor, manual review. Real follower base, engagement above category median, channel hygiene.
Pillar 04 · Owned

Email & SMS — Owned-Audience Moat

Owned audiences are the asset that survives every platform ban. Target: email and SMS drives 30 to 50 percent of total revenue within six months.

  • Klaviyo + an SMS provider that tolerates the category. Postscript currently; note Attentive has been removing peptide brands.
  • Flows: welcome, abandoned cart, post-purchase, win-back, VIP / research-tier.
  • Cadence: weekly newsletter, 2-4 SMS per month, drop-aware.
  • Suppression hygiene and unsub compliance shipped from day one.
Pillar 05 · Organic

SEO & Content

Long-tail compound pages compound. Comparison guides, dosage research roundups, "what the literature says" formats. Trust queries win.

  • Compound pages per peptide: BPC-157, TB-500, Tirzepatide, Retatrutide, Cagrilintide, MOTS-c, GHK-Cu, Selank, Semax, Epitalon.
  • COA, purity, mass spec pages indexed and surfaced. Reduce CAC.
  • Reddit organic presence in r/Peptides, r/PeptideSources, r/MoreNutrition.
  • Schema for AEO and GEO citation in ChatGPT, Perplexity, Google AI Overviews.
Pillar 06 · Paid

Paid Media

Paid media supports. It does not lead. We use it to feed the email and SMS engine, not to sell peptides directly.

  • Google brand-search only. The safe baseline that captures branded intent.
  • Meta TOFU lead-gen on adjacent content (longevity, recovery, sleep). Never directly to peptide PDPs.
  • YouTube and podcast host-reads. The highest-ROI paid lever in this category.
  • Account hygiene protocols to extend ad-account lifespan as long as possible.
Infographic 01 · Compliance pyramid

Risk exposure by source.

Brand copy is the base. Lowest risk if disciplined. Influencer claims are the apex. Highest risk, but contractually transferable through MSA.

Brand copy (PDP, hero, ads)Lowest riskIf disciplined: RUO, in-vitro, COA-led, no structure/function claims.
Email / SMSModerateOwned channel. Disclaimers and opt-in compliance critical.
Paid ads (brand-search, TOFU)HigherPlatform bans. Account hygiene buys runway, not approval.
Influencer / affiliate claimsHighestApex risk, but contractually transferable through MSA + indemnification.
Infographic 02 · Channel ROI quadrant

Where the dollars actually compound.

X-axis: effort to operate. Y-axis: ROI for peptide brands. Loser quadrant labeled "account death."

EFFORT → ↑ ROI HIGH ROI · LOW EFFORT HIGH ROI · HIGH EFFORT ACCOUNT DEATH LOW ROI · LOW EFFORT Email /SMS Affiliate codes Micro/Nano influencer SEO long-tail Podcast reads G. brand search Meta TOFU Direct Meta peptide ads banned

Want this 6-pillar playbook applied to your brand? Book a 30-min strategy call. Operator to operator. Yes-fit or no-fit on the call.

Book a Strategy Call
The trust stack · Infographic 03

Lab data is the marketing.

Peptide buyers want science. We make it scannable on every product page. COA, purity, mass spec, endotoxin, sourcing, reconstitution research. On-page, not buried PDFs.

COAPer batch
Third-party lab data per batch. Batch ID, test date, lab name. On-page, not a buried PDF. The single most-clicked element on a peptide PDP.
PurityHPLC / HPLC-MS
Standardize 98%+ purity disclosure across the catalog. Display as a clean badge with the lab method (HPLC, HPLC-MS) and the batch reference.
Mass Specm/z match
Mass spectrometry result showing m/z matches expected molecular weight. The signal that converts a research-grade buyer who knows to ask.
EndotoxinWhere relevant
Endotoxin testing for compounds where it matters. LAL test results, batch reference, lab name. Surfaced on the PDP.
SourcingSynthesis transparency
Sourcing and synthesis transparency where defensible. Lab partner, country, GMP status. Builds the gap between you and the gray market.
ReconstitutionIn-vitro framing
Reconstitution research instructions framed for in-vitro use. RUO disclaimer placement. Avoid dosage language that crosses structure/function lines.
Infographic 04 · Influencer tier map

Nano + Micro carry the load.

Macro is selective. Mega is generally avoided in pure RUO. Tiers visually weighted to the recommendation.

TierFollowersTypical CPMEngagementCompliance riskUse case
Nano1K - 10K$5 - $205 - 12%ManageableEngine. Hyper-niche. Highest engagement per dollar.
Micro10K - 100K$15 - $503 - 7%ManageableVolume engine. Health pros, podcasters, longevity, athletes.
Macro100K - 1M$50 - $2001 - 3%SelectiveCosmetic peptides, nootropic-adjacent SKUs with ad cover.
Mega1M+$200+<1%HighAvoided in pure RUO. Licensed compounding plays only.
Infographic 05 · 90-day timeline

Day-zero to compounding revenue.

Foundation, then engine, then compounding. We do not over-promise day-30 results. We promise day-90 systems.

Days 0-30

Foundation
  • Brand copy compliance audit complete
  • Affiliate platform live (Refersion / GoAffPro / custom)
  • MSA + claim library shipped
  • Klaviyo + Postscript flows live (welcome, AC, post-purchase)
  • Google brand-search campaigns launched
  • COA / purity / mass spec presentation standardized

Days 30-60

Engine
  • 30-50 active affiliate codes
  • Private Telegram or Discord launched, first drop
  • SEO compound pages live (top 10 peptides)
  • Reddit organic presence active
  • Meta TOFU on adjacent content running
  • Email/SMS revenue compounding (5-15% of total)

Days 60-90

Compounding
  • 50-100 active affiliate codes
  • First influencer drops shipped, performance data live
  • Podcast / YouTube host-reads live (1-3 placements)
  • Email/SMS at 20-30% of total revenue, climbing
  • Recruiting engine self-sustaining
  • Performance audit, retire underperformers
Laws & regulations

What we know cold about peptide compliance.

PELORA is not a law firm. We do not provide legal advice. We do know the playing field cold, and we work alongside qualified counsel on every engagement.

FDA · FD&C Act

21 U.S.C. § 321 — drug definition

If brand copy implies a substance is intended for diagnosis, cure, mitigation, treatment, or prevention of disease, FDA can classify it as an unapproved drug. Brand-side copy stays sterile. RUO framing, in-vitro context, no disease/cure/treat language. The 2024-2025 warning letter wave hit this exact line.

FDA · DSHEA

Structure / function rules (21 CFR 101.93)

Even compliant supplements cannot make disease claims. Structure/function claims must be substantiated and disclaimed. For peptides, the safer path is to avoid structure/function claims on brand-side copy and let affiliates carry storytelling under MSA.

FTC · Endorsements

16 CFR Part 255 — revised 2023

Endorsers must disclose material connections clearly and conspicuously. #ad, #sponsored, paid partnership tags are not optional. Brands are responsible for monitoring endorsers. PELORA's MSA template includes mandatory FTC disclosure clauses and content review workflow.

FTC · substantiation

Reasonable basis standard

Any objective claim made in advertising must be supported by competent and reliable scientific evidence at the time the claim is made. Affiliate claim libraries are scoped to what is actually substantiated, not what reads well.

DEA / CSA

Controlled Substances Act

Most research peptides are not scheduled. Specific compounds (e.g. some growth-hormone secretagogues, certain prohormone peptides) sit closer to the line. We do not market controlled substances. We are explicit on the strategy call about compounds we will and will not handle.

State law

California Prop 65, NY AG, FL DBPR

State enforcement varies. California Prop 65 affects ingredient warnings; New York AG has gone after supplement claims; Florida regulates compounding pharmacy interfaces. Brand legal counsel runs the state-by-state review. We ship copy that fits inside the strictest state's rules by default.

Disclaimer: This section summarizes how PELORA structures peptide marketing engagements relative to current US enforcement patterns. It is not legal advice. Every peptide brand should retain qualified healthcare-marketing counsel for FDA, FTC, DEA, and state-by-state review. We work alongside legal teams, not in place of them.
Research basis

Every claim on this page traces to a public source.

We do not make up statistics. Below is the research foundation behind PELORA's peptide marketing playbook. Click any source to verify.

FDA · Warning Letters

2024-2025 enforcement wave on peptide brand-side claims.

FDA Warning Letter database is publicly searchable. Multiple letters in 2024-2025 cited unapproved-drug structure/function language on peptide brand websites and PDPs. The pattern: brand copy crossed the line, not affiliates.

FDA Warning Letter database →
FTC · 16 CFR Part 255

Endorsement guides revised June 2023.

Federal Trade Commission updated endorsement and testimonial rules in 2023. Material connections between brand and influencer must be clearly and conspicuously disclosed (#ad, #sponsored, paid partnership). Brands are responsible for monitoring endorsers.

FTC endorsement guides →
Wyzowl · 2025 Video Report

89% of consumers convinced by brand video.

Wyzowl's annual State of Video Marketing report (2025) found 89% of consumers say a brand video has convinced them to buy a product or service. 91% of businesses now use video as a marketing tool. Highest signal in regulated wellness categories.

Wyzowl 2025 report →
Grand View Research

GLP-1 + peptide therapeutics market projection.

The global peptide therapeutics market is projected to exceed $52 billion by 2030, with GLP-1 receptor agonists driving the largest growth. Research-only peptide e-commerce sits adjacent and grows on a parallel curve.

Grand View Research →
EKRA / 18 U.S.C. § 220

Eliminating Kickbacks in Recovery Act of 2018.

Federal statute prohibiting kickbacks for patient referrals to clinical treatment, recovery homes, or labs. Reach extends to behavioral health and wellness adjacent. PELORA structures all paid relationships as flat-fee marketing services to stay clear.

DOJ EKRA enforcement →
Postscript · Public Policy

SMS provider tolerance varies by category.

Postscript publicly accepts peptide brands operating under proper RUO compliance framing as of 2025. Attentive has been removing peptide brands. Klaviyo policies on email side remain peptide-friendly with disciplined copy. Choosing the right stack is half the work.

Postscript industry policy →
Reuters · Meta enforcement

Meta peptide ad removal waves 2023-2024.

Major enforcement actions documented in trade press (Reuters, AdAge, Marketing Brew) cite Meta classifying compounded peptide ads as restricted pharmaceutical content. Direct PDP ads do not pass review. Account deplatforming risk is real.

Meta regulated goods policy →
DSHEA · 21 CFR 101.93

Structure / function claim rules.

Even compliant supplements cannot make disease claims. Structure/function claims must be substantiated and disclaimed. The safe path for peptide brands is to avoid structure/function on brand-side copy and let affiliates carry storytelling under MSA.

FDA structure/function guidance →
The format we produce

Long-form interviews. The exact creative engine we install for peptide brands.

Founders, scientific advisors, formulators, athletes. Plays inline below, no need to leave the page. Same camera, same edit, same distribution playbook for every client.

Cambria Judd MD interview on functional medicine, by Preston Durnford Cambria Judd, MD Functional medicine · 1h 26m

Functional Medicine, Spirituality & Healing.

Dr Kristi Vaughan functional medicine interview Dr. Kristi Vaughan Functional medicine · 1h 01m

Functional Medicine for Addiction & Mental Health.

Maurice Benard State of Mind interview with Preston Durnford State of Mind Featured · Maurice Benard

3x Emmy winner · General Hospital.

Engagement pattern

What a Growth-tier engagement looks like.

Anonymized data based on PELORA operating patterns. Real client figures shared on the strategy call under NDA. We do not name brands without written permission.

Methodology in action · Growth tier ($50K-$250K MRR brand)

The four numbers we drive.

Targets observed across PELORA peptide engagements at the Growth tier. Range, not guarantee. Outliers exist on both sides.

28%
Email + SMS share of total revenue by month 4. Target band: 20-35%.
62
Active affiliate codes by month 3. Target band: 50-100. Driven by recruiting cadence.
14
SEO compound pages ranking on page 1-2 by month 6. Long-tail peptide research queries.
2.4x
Affiliate-driven revenue increase from baseline by month 6. Performance tail kicks in at incremental revenue above baseline.

Source: PELORA operating data across peptide engagements. Anonymized at brand level. Figures are observed range targets, not guarantees. The performance tail (5-10% on incremental affiliate-driven revenue above baseline) aligns our incentives with growth.

How we charge

Retainer + performance tail. We make more when you make more.

Most growth-stage peptide brands reinvest 20 to 25 percent of gross monthly revenue into marketing. PELORA fits inside that envelope.

StageMonthly RevenuePELORA RetainerIncludes
StarterCompliance + foundation
$20K - $50K$5K - $10K/month
Compliance audit, affiliate program build, email/SMS setup, Google brand-search.
GrowthMost peptide founders
$50K - $250K$10K - $25K/month
All Starter + influencer recruiting, SEO content engine, Meta TOFU on adjacent content.
Scale$1M ARR threshold
$250K - $1M$25K - $50K/month
All Growth + full content team, podcast / YouTube host-reads, ad-account hygiene at scale.
EnterpriseVertical exclusivity
$1M+$50K+retainer + performance
Full-stack ops, category-adjacent SKU launches, vertical exclusivity, performance tail.

Performance tail

On incremental affiliate-driven revenue above baseline, we take a 5 to 10% revenue share. We make more when you make more.

Not in retainer

Ad spend, influencer payouts, software (Klaviyo, Postscript, Refersion) flow through the brand directly. Retainer is agency labor, strategy, ops.

Vertical exclusivity

One client per peptide-revenue niche per quarter. Founders are buying our refusal to work with their direct competitor as much as the playbook.

Fit filter

Who we work with. And who we don't.

Honesty saves both sides time. We are explicit on the strategy call about whether the playbook translates.

Yes · We work with

  • Research peptide brands ($20K-$2M+/month, RUO-positioned)
  • GLP-1 / compounded peptide brands (telehealth + pharmacy structure)
  • Longevity supplement brands using peptide bridges
  • Cosmetic peptide brands (topical, RUO with appropriate framing)
  • Founders willing to invest in compliance as a system
  • Brands building owned audiences: email, SMS, affiliate, community

No · We do not work with

  • Brands selling controlled substances
  • Brands unwilling to invest in compliance infrastructure
  • Brands looking for cloaked Meta or Google peptide ads
  • Brands without basic e-commerce hygiene (no Shopify, no clean PDPs)
  • Brands seeking guaranteed revenue numbers we cannot honestly deliver
  • Brands that want to skip the affiliate program for paid media only
Methodology in action

The first 90 days, sequenced.

We never fabricate brand names or numbers. Below is the methodology every PELORA peptide engagement follows. Real case study figures shared on the strategy call under NDA.

30Days 0-30 · Foundation

Compliance + engine build.

  • Full brand-copy audit shipped within 7 days
  • Affiliate platform live, MSA + claim library deployed
  • Klaviyo + Postscript installed, 5 lifecycle flows live
  • Google brand-search campaigns running
  • COA / purity / mass spec presentation standardized
60Days 30-60 · Engine

Affiliate + SEO + TOFU compounding.

  • 30-50 active affiliate codes onboarded
  • Private Telegram or Discord launched, first drop
  • 10-15 SEO compound pages live and indexed
  • Meta TOFU on adjacent content
  • Email/SMS at 5-15% of total, climbing
90Days 60-90 · Compounding

Influencer + podcast + audit.

  • 50-100 active affiliate codes, leaderboard live
  • First influencer drops shipped
  • 1-3 podcast / YouTube host-reads booked
  • Email/SMS at 20-30% of total revenue
  • First monthly performance audit
FAQ

Peptide founder questions, answered.

Is RUO peptide marketing legal?

RUO (Research Use Only) is a compliance posture, not a marketing license. Legal in the US when brand-side copy stays disciplined: research-only language, in-vitro context, COA presentation, age-gating, no disease/structure-function claims. Affiliate and influencer claims that are properly contracted under MSA with claim restrictions and indemnification can carry the human-use storytelling. PELORA Marketing is not a law firm.

Will Meta or Google ever stop banning peptide ads?

Direct peptide PDP ads on Meta and Google are functionally dead since the 2023 enforcement waves. Brands winning past $10M ARR built on coded affiliates, micro/nano influencers, owned email and SMS, long-tail SEO, and podcast or YouTube host-reads. PELORA runs Google brand-search as a safe baseline and Meta TOFU lead-gen on adjacent content (longevity, recovery, sleep) that feeds the email/SMS engine, never directly to peptide product pages.

How fast can you build an affiliate program?

Platform live in days. MSA, claim library, content approval workflow, and tier structure ready in week one. 50-100 micro and nano affiliates onboarded in 90 days across bodybuilding, biohacking, longevity, men's health, and peri/post-menopausal women's health. Private Telegram or Discord with monthly drops and leaderboard live by day 30.

Do you guarantee revenue?

We do not guarantee specific revenue numbers. We do guarantee process, deliverables, and a defined cadence: compliance audit complete in week one, affiliate program live in week two, email/SMS flows shipping by day 30, first influencer drops by day 60, content engine compounding by day 90. The performance tail aligns our incentives.

What happens if a brand gets an FDA warning letter?

We pause customer-facing copy that touches the cited claim language within 24 hours, audit affiliate and influencer published material, document a remediation plan, and coordinate with the brand's legal counsel on the formal response. PELORA does not provide legal advice; counsel runs the response, we run the copy and channel remediation.

How do you vet influencers for compliance?

Every influencer signs an MSA before they receive a code. The MSA defines: claim restrictions, required FTC disclosures (#ad, #sponsored, paid partnership), content approval workflow, indemnification language, and termination triggers. Recruiting filters: real follower base (Modash, HypeAuditor), engagement above category median, channel hygiene.

Do you work with GLP-1 or compounded peptide brands?

Yes. Compounded GLP-1 brands (semaglutide, tirzepatide) operating through licensed telehealth and compounding pharmacy partnerships have a different compliance frame than RUO research peptides: licensed-provider copy, medical disclaimers, FDA-compliant claims, and Meta/Google healthcare review queues. We build for both routes.

What does the engagement cost?

Most growth-stage peptide brands reinvest 20 to 25 percent of gross monthly revenue into marketing. Starter ($20K-$50K/mo): $5K-$10K. Growth ($50K-$250K/mo): $10K-$25K. Scale ($250K-$1M/mo): $25K-$50K. Enterprise ($1M+/mo): $50K+ retainer plus performance tail. See full pricing table ↑

Book a strategy call

30 minutes. Operator to operator.

Your category, your spend, your funnel. Preston runs the call personally. No pitch deck. Yes-fit or no-fit on the call. If we are a fit, scope follows in 72 hours.

Book a Strategy Call (833) 598-2254

We accept a limited number of peptide clients per quarter to protect category exclusivity.

Legal disclosure: PELORA Marketing does not provide legal advice. All compliance recommendations should be reviewed by qualified counsel. Brand decisions about RUO framing, FDA structure/function language, FTC endorsement compliance, and state-specific peptide regulations are the responsibility of the brand and its retained legal team. We work alongside legal, not in place of it.
Book a strategy call